Role of surgery (cytoreductive nephrectomy and metastasectomy) in the management of metastatic renal cell carcinoma: A literature review

被引：1

作者：

Arroua, F. ^{[1
]}

Maurin, C. ^{[1
]}

Carcenac, A. ^{[1
]}

Ragni, E. ^{[1
]}

Rossi, D. ^{[1
]}

Bastide, C. ^{[1
]}

机构：

[1] CHU Nord Marseille, Serv Urol, F-13915 Marseille 20, France

来源：

PROGRES EN UROLOGIE | 2010年 / 20卷 / 13期

关键词：

Cytoreductive nephrectorny; Metastatic renal cell carcinoma; Metastasectorny; Targeted therapy; TYROSINE KINASE INHIBITORS; NEPHRON-SPARING SURGERY; SYSTEMIC THERAPY; INTERFERON-ALPHA; PROGNOSTIC-FACTORS; SPONTANEOUS REGRESSION; STRATIFICATION TOOL; SCORING ALGORITHM; PREDICT SURVIVAL; PRIMARY TUMOR;

D O I：

10.1016/j.purol.2010.06.001

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Cytoreductive nephrectomy is an established treatment option prior immunotherapy in well-selected patients with metastatic renal cell carcinoma. With the recent introduction of new targeted agents, the role of surgery has been source of controversy. This review examines the role of cytoreductive nephrectomy during the immunotherapy era, then in the new targeted therapies era. This review also summarizes the optimal timing of these treatments, the prognostic factors predicting outcome following cytoreductive nephrectomy, the role of metastasectomy, partial and laparoscopic cytoreductive nephrectomy. (c) 2010 Elsevier Masson SAS. All rights reserved.

引用

页码：1175 / 1183

页数：9

共 50 条

[1] The Role of Surgery in Advanced Renal Cell Carcinoma: Cytoreductive Nephrectomy and Metastasectomy
Karam, Jose A.
Wood, Christopher G.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (04) : 753 - +
[2] Role of cytoreductive nephrectomy in renal cell carcinoma
Chiong, Edmund
Wood, Christopher G.
Margulis, Vitaly
FUTURE ONCOLOGY, 2009, 5 (06) : 859 - 869
[3] The evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma
Graham, Jeffrey
Bhindi, Bimal
Heng, Daniel Y. C.
CURRENT OPINION IN UROLOGY, 2019, 29 (05) : 507 - 512
[4] Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis
Britton, Cameron J.
Andrews, Jack R.
Wallis, Christopher J. D.
Sharma, Vidit
Leibovich, Bradley C.
Thompson, R. Houston
Boorjian, Stephen A.
Bhindi, Bimal
Costello, Brian A.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (03) : 125 - 136
[5] Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma: Is There Still a Debate?
Vives Dilme, Roser
Gomez Rivas, Juan
Campi, Riccardo
Puente, Javier
Jerez, Tamara
Enikeev, Dmitry
Esperto, Francesco
Moreno Sierra, Jesus
CURRENT UROLOGY REPORTS, 2021, 22 (11)
[6] The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
Studentova, Hana
Spisarova, Martina
Kopova, Andrea
Zemankova, Anezka
Melichar, Bohuslav
Student, Vladimir
CANCERS, 2023, 15 (15)
[7] Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy
Richey, S. L.
Culp, S. H.
Jonasch, E.
Corn, P. G.
Pagliaro, L. C.
Tamboli, P.
Patel, K. K.
Matin, S. F.
Wood, C. G.
Tannir, N. M.
ANNALS OF ONCOLOGY, 2011, 22 (05) : 1048 - 1053
[8] Role of metastasectomy in the management of renal cell carcinoma
Mikhail, Mark
Chua, Kevin J. J.
Khizir, Labeeqa
Tabakin, Alexandra
Singer, Eric A. A.
FRONTIERS IN SURGERY, 2022, 9
[9] Cytoreductive nephrectomy in metastatic renal cell carcinoma (Review)
Dahm, Philipp
Ergun, Onuralp
Uhlig, Annemarie
Bellut, Laura
Risk, Michael C.
Lyon, Jennifer A.
Kunath, Frank
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (06):
[10] Role of metastasectomy in metastatic renal cell carcinoma
Thomas, Arun Z.
Adibi, Mehrad
Borregales, Leonardo D.
Wood, Christopher G.
Karam, Jose A.
CURRENT OPINION IN UROLOGY, 2015, 25 (05) : 381 - 389

← 1 2 3 4 5 →